OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Autor: Aurora, SK1, Dodick, DW2, Turkel, CC3, DeGryse, RE3, Silberstein, SD4, Lipton, RB5, Diener, HC6, Brin, MF7
Zdroj: Cephalalgia. Jul2010, Vol. 30 Issue 7, p793-803. 11p.
Databáze: Academic Search Ultimate